Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public health crisis that demands the timely creation of new therapeutics and viral detection. Owing to their high specificity and reliability, monoclonal antibodies (mAbs) have emerged as powerful tools to treat and detect numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Yu-Chyi, Lu, Ruei-Min, Su, Shih-Chieh, Chiang, Pao-Yin, Ko, Shih-Han, Ke, Feng-Yi, Liang, Kang-Hao, Hsieh, Tzung-Yang, Wu, Han-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724751/
https://www.ncbi.nlm.nih.gov/pubmed/34983527
http://dx.doi.org/10.1186/s12929-021-00784-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724751/
https://www.ncbi.nlm.nih.gov/pubmed/34983527
http://dx.doi.org/10.1186/s12929-021-00784-w

Ejemplares similares